Cargando…
Thioredoxin interacting protein (TXNIP) is a novel tumor suppressor in thyroid cancer
BACKGROUND: Thyroid cancer is the most common endocrine malignancy, and many patients with metastatic differentiated thyroid cancer (DTC), poorly differentiated thyroid cancer (PDTC), and anaplastic thyroid cancer (ATC) fail to respond to conventional therapies, resulting in morbidity and mortality....
Autores principales: | Morrison, Jennifer A, Pike, Laura A, Sams, Sharon B, Sharma, Vibha, Zhou, Qiong, Severson, Jill J, Tan, Aik-Choon, Wood, William M, Haugen, Bryan R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995095/ https://www.ncbi.nlm.nih.gov/pubmed/24645981 http://dx.doi.org/10.1186/1476-4598-13-62 |
Ejemplares similares
-
ODP251 Thioredoxin-Interacting Protein (Txnip) And Cellular Senescence: Potential Adverse Effects of Txnip Deficiency.
por: Abubaker, Mohammed, et al.
Publicado: (2022) -
Thioredoxin/Txnip: Redoxisome, as a Redox Switch for the Pathogenesis of Diseases
por: Yoshihara, Eiji, et al.
Publicado: (2014) -
Thioredoxin-Interacting Protein (TXNIP) with Focus on Brain and Neurodegenerative Diseases
por: Tsubaki, Haruka, et al.
Publicado: (2020) -
PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells
por: Wood, William M., et al.
Publicado: (2011) -
A role for thioredoxin-interacting protein (Txnip) in cellular creatine homeostasis
por: Zervou, Sevasti, et al.
Publicado: (2013)